Advances and drawbacks of the adaptation to serum-free culture of CHO-K1 cells for monoclonal antibody production by Rodrigues, E. et al.
Advances and Drawbacks of the Adaptation
to Serum-Free Culture of CHO-K1 Cells for Monoclonal
Antibody Production
Maria Elisa Rodrigues & Ana Rita Costa &
Mariana Henriques & Philip Cunnah &
David W. Melton & Joana Azeredo & Rosário Oliveira
Received: 7 September 2012 /Accepted: 26 December 2012 /
Published online: 11 January 2013
# Springer Science+Business Media New York 2013
Abstract Currently, mammalian cell technology has become the focus of biopharmaceutical
production, with strict regulatory scrutiny of the techniques employed. Major concerns about
the presence of animal-derived components in the culture media led to the development of
serum-free (SF) culture processes. However, cell adaptation to SF conditions is still a major
challenge and limiting step of process development. Thus, this study aims to assess the
impact of SF adaptation on monoclonal antibody (mAb) production, identify the most
critical steps of cell adaptation to the SF EX-CELL medium, and create basic process
guidelines. The success of SF adaptation was dependent on critical steps that included
accentuated cell sensitivity to common culture procedures (centrifugation, trypsinization),
initial cell concentration, time given at each step of serum reduction, and, most importantly,
medium supplements used to support adaptation. Indeed, only one of the five supplement
combinations assessed (rhinsulin, ammonium metavanadate, nickel chloride, and stannous
chloride) succeeded for the Chinese hamster ovary-K1 cell line used. This work also
revealed that the chemically defined EX-CELL medium benefits mAb production in com-
parison with the general purpose Dulbecco’s Modified Eagle’s Medium, but the complete
removal of serum attenuates these positive effects.
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Introduction
Mammalian cells are of great interest for biopharmaceutical applications, namely in the
industrial production of recombinant therapeutic glycoproteins, due to their ability to
perform human-like post-translational modifications resulting in a fully active product [18,
24, 30, 32]. One of the most important cell lines used in the production of these recombinant
proteins, such as monoclonal antibodies (mAbs), is the Chinese hamster ovary (CHO) cell
line, which has attractive features for large-scale production such as the support of a stable
and high-level product expression over time, scalability, and the ability to provide proper
post-translational processing [22].
A major objective of the biopharmaceutical industry is to decrease costs while increasing the
production yield. Furthermore, a robust culture system with predictable and reliable high-
density cell growth and/or specific cell productivity is greatly desired [13]. However, with
the increasing number of mAbs being used as therapeutic agents, methods employed for their
production are coming under strict regulatory scrutiny, which may interfere with the optimal
production process [33]. One of the areas of main concern for regulatory entities is the presence
of animal-derived components in the media employed [22]. Indeed, the original adherent
growth conditions of most mammalian cells, such as CHO, require the use of serum-
containing medium [2, 17, 19, 23]. However, the use of serum in the culture media has many
drawbacks. From a practical point of view, serum is an ill-definedmixture of components which
raises ethical and animal welfare problems regarding its harvest and collection, and there are
constraints in terms of global supply versus demand [2, 8, 18, 24, 33]. Concerning cell
biological perspectives, the disadvantages of serum supplementation are manifold: (1) serum
batches display quantitative and qualitative variations in their composition and thus introduce a
serious lot-to-lot variability; (2) serum may contain many different proteins, which can hinder
product purification; (3) serum can also interfere with the effect of hormones or growth factors
when studying their interaction with cells; (4) serum can be a potential source of microbial
contaminants, such as fungi, bacteria, viruses, mycoplasma, and prions, posing a risk of
transmission of diseases to the end product used by humans; and (5) serum is associated with
high-costs [2, 8, 18, 19, 23, 24, 33]. Considering all these reasons, it is essential to develop a
simple cell adaptation process for the culture of cells in serum-free, animal component-free, or
protein-free medium conditions [18, 22, 26, 31].
Recently, there have been many efforts to develop serum-free media for the production of
therapeutic proteins in mammalian cell culture [3, 25, 27]. This has led to the development
of several commercial serum-free media specific for CHO cell culture [19]. However, serum-
free medium development is a commercially competitive field, and the composition of most
of these media is patented, making further improvements difficult [19].
Mammalian cell growth can be adapted to serum-free media through progressive reductions
of serum concentrations [5, 26]. This gradual reduction over time increases the probability of
successful adaptation to low-serum or serum-free media [23] by allowing the self-adjustment of
the cells to the environment, with the time required depending on the cell line and the
composition of the media [10]. To achieve the final step of adaptation, it is common to add
supplements that support cell growth, such as commercial serum substitutes, defined proteins,
or small molecules such as amino acids or trace elements. Among these, the use of small
molecules is the most difficult to achieve, but it may ultimately prove to be the most useful [5].
During the process of adaptation, it is critical to monitor the cell growth rate since its
increase is the first sign of a successful adaptation [18, 23]. Furthermore, the measurement of
protein production is also critical [5, 18, 21] and, depending on the product or cell type, gain
or loss of productivity can be observed [21].
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The transition to serum-free conditions is not straightforward. However, once cells have
been adapted, researchers can benefit from improved control over culture conditions,
improved reproducibility between cultures, consistency of media that avoids the need to
screen batches, potential ease in scale-up operation, simplicity in downstream processing,
reduced risk of virus contamination, and reduced costs [3, 5, 8, 25, 27, 29].
This study aims to evaluate a methodology for the adaptation of CHO-K1 cells, producing
the mAb CAB051, to grow in the chemically defined serum-free medium EX-CELL CHO
DHFR-, and assess its impact on mAb production, as well as to identify themost critical steps of
the process. To accomplish this, a methodology of gradual adaptation was implemented,
supported by medium supplementation with different combinations of trace elements.
Materials and Methods
Cell Lines and Cell Culture
Three cell types were used in this study: cell line A—the main CHO-K1 cell line transfected
with the CAB051 mAb (Biotecnol SA, Lisbon, Portugal) by OSCARTM technology
(University of Edinburgh, Scotland); and two additional cell lines that were used to assess
the impact of transfection on the process of adaptation, namely cell line B—the original non-
producing CHO-K1 cell line (ATCC), and cell line C—a CHO-K1 cell line also producing the
CAB051 mAb but transfected by a common technology (kindly provided by Biotecnol SA).
The different cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-
Aldrich, Dorset, UK) supplemented with 10 % of fetal bovine serum (FBS, Sigma-Aldrich),
and with 1×hypoxanthine–aminopterin–thymidine (HAT, Sigma-Aldrich) only for cell line
A at 37 °C and in a humidified atmosphere at 5 % CO2.
Adaptation Methodology
Direct Adaptation to Serum-Free Medium
Cells growing in serum-containing medium were inoculated, in 25-cm2 flasks, at a viable
cell density of 2×105 cells per milliliter in a 1:1 mixture of serum-containing medium
(DMEM supplemented with FBS) and serum-free medium (EX-CELL CHO DHFR- medi-
um, Sigma-Aldrich). After reaching a density of 1×106 cells per milliliter, the cells were
subcultured at an initial density of 2×105 cells per milliliter into a medium containing
increasing proportions of EX-CELL CHO DHFR- medium, first at 1:3 mix and then 1:7
(serum-containing medium/serum-free medium). The cells were considered adapted only
when the cell density reached 1×106 cells per milliliter, with at least 90 % cell viability.
Gradual Adaptation to Serum-Free Medium
First Experiment Cell line A growing in serum-containing medium was seeded in 24-well
plates at a viable cell density of 2×105 cells per milliliter, in duplicate, with five different
combinations of medium supplements (insulin and trace elements), as described in Table 1.
Negative (cells growing in serum-containing medium without additional supplementation)
and positive (cells growing in serum-containing medium with gradual reduction of serum
percentage without additional supplementation) controls were also assessed. A methodology
of gradual adaptation was implemented based on sequential reduction of serum percentage
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by half at each step, after assuring successful cell adaptation from the previous step. When
the cultures reached 0.625 % of serum, the medium composition was gradually
switched to the chemically defined serum-free EX-CELL CHO DHFR- medium. It
should be noted that cells were subcultured in six-well plates and later in 25-cm2 flasks
when they had reached 90 % confluence. At every passage step of the process, samples
were taken for analysis of cell productivity. Cell concentration and viability were
assessed by trypan blue exclusion.
Second Experiment Problems were detected during the first experiment leading to the
development of an improved methodology of cell adaptation with the following modifica-
tions: cells were cultured in 25-cm2 flasks with a higher initial cell concentration (4×105
cells per milliliter); cell lines B and C were also used to assess the possible impact of
transfection on the process of adaptation; only combinations C2, C3, and C5 (Table 1) were
tested; procedures that were harsh to the cells, such as those involved with subculture
(centrifugation and the use of enzymes) were avoided; and the time given to the cells to
adapt at each step of the process was increased.
Since subculture procedures were being avoided, a quantitative analysis of cell concen-
tration was not possible during the first steps of the process when cells were growing
adherently. Therefore, to allow a qualitative assessment of this parameter, micrographs were
taken during these steps. After the cells started to detach and grow in suspension, cell
concentration and viability were assessed by the usual trypan blue exclusion method.
Cryopreservation and Thawing of Serum-Free Cells
At different steps of the process of cell adaptation to serum-free medium cells were
cryopreserved. Initially, this was done using the routine procedure, preserving cells in
DMEM supplemented with the corresponding percentage of serum and 5 % dimethyl
sulfoxide (DMSO, Frilabo, Maia, Portugal) and using the Mr. Frosty system (Sigma-
Aldrich) to provide a freezing rate of approximately −1 °C/min. As some problems were
found during the recovery of the frozen cells, an optimization of the cryopreservation and
thawing procedures was attempted. More rigorous and delicate procedures were applied,
consisting of preserving cells in 40 % conditioned medium (medium in which cells were
Table 1 Composition of the different combinations of medium supplements assessed in the gradual meth-
odology of cell adaptation to serum-free medium
Medium supplement Function Concentration (M) Combination
1 2 3 4 5
RhInsulin Growth factor 3.43×10−7 X X X X X
Copper sulfate (CuSO4) Proliferation 1.00×10
−8 X X X X
Zinc sulfate (ZnSO4) Proliferation 5.33×10
−6 X X X X
Sodium selenite (Na2SeO3) Antioxidant 1.00×10
−7 X X X X
Ammonium iron citrate (FeC6H5O7.NH4OH) Proliferation 3.57×10
−4 X X
Ferrous ammonium sulfate (NH4Fe(SO4)2) Proliferation 3.76×10
−4 X X
Ammonium metavanadate (NH4VO3) Unknown 5.47×10
−9 X X X
Nickel chloride (NiCl2) Unknown 1.00×10
−9 X X X
Stannous chloride (SnCl2) Unknown 6.33×10
−10 X X X
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growing), 55 % DMEM or EX-CELL supplemented with the corresponding serum percent-
age, and 5 % DMSO, by adding this medium to the cells in a dropwise manner. To thaw
cells, they were warmed at 37 °C until only an ice crystal remained, the growth medium was
added dropwise, the cells were centrifuged (180 g, 5 min), and fresh growth medium was
once again added dropwise.
Antibody Quantification
Samples were analyzed for antibody productivity by enzyme-linked immunosorbent assay
(ELISA) following a confidential procedure described in SOP 2008-01 ANL from Biotecnol
SA, Portugal. Briefly, plates were coated with capture antibody overnight and blocked for
45 min at room temperature. Dilutions of the samples were added, as well as a standard of
known concentration and a quality control, and the plates incubated for 2 h at 37 °C. The
detection antibody was added and the plates incubated for 2 h at room temperature, after
which, a 3,3′,5,5′-Tetramethylbenzidine (TMB, Sigma-Aldrich) substrate solution was added
and allowed to react for 10 min at room temperature. After stopping the reaction, absorbance
was read at 450 nm.
Statistical Analysis
Statistical analysis was performed using SPSS software (Statistical Package for the Social
Sciences). MAb production data were assessed using one-way analysis of variance with
Bonferroni’s test and a confidence level of 95 %.
Results and Discussion
Evaluation of the Cell Adaptation Methodology
First Experiment
In this work, a first attempt to adapt cell line A (CHO-K1 cell line transfected with CAB051
mAb by OSCARTM technology) to serum-free conditions was made. The timeline of the
process of adaptation used and the main observations are shown in Fig. 1. In this first
experiment, the percentage of serum was reduced to no more than 0.31 %, level at which cells
died after 45 days of culture. These less positive results were related to different factors. The
first consisted of the use of a low initial cell concentration (2×105 cells per milliliter) in small
culture surfaces (24-well plates). In fact, with a procedure so demanding to the cells, the use of
higher initial cell concentration and higher culture surface may result in a higher number of
surviving cells, increasing the probability of successful adaptation. Furthermore, the use of 24-
and 6-well plates poses an extra problem for cell concentration monitoring since cells tend to
concentrate in the middle of the well, leading to irregular sampling and deceptive results.
Second, since cells are much more sensitive during this demanding process of adaptation,
the use of common procedures in cell culture, like centrifugation and the use of enzymes
(e.g. trypsin) can be damaging. This deleterious effect was observed when cells were
subcultured into new culture flasks and in some steps of serum reduction. In these steps, a
decrease in cell viability and changes of morphology, with cells becoming smaller and
irregular, were observed. Therefore, it is concluded that such harsh culture procedures
should be avoided whenever possible.
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Third, the continuous reduction of cell concentration during the process of adaptation
may also be a consequence of insufficient time given to a full adaptation of cells at each step
of the process. Indeed, time is probably the most important factor for the success of serum-
free adaptation, and cells should be given enough time to acquire a healthy appearance and
an obvious growth at each stage of serum reduction.
Concerning the different combinations of trace elements tested, it was observed that C1
and C4 had the worst effects on cell adaptation. With these combinations, cells became fully
detached with low viabilities very early in the process (2.5 % serum) and ended up dying at
0.625 % serum (day29). This was most likely caused by the presence of the trace element
ammonium iron citrate, common to both combinations and not present in C2, C3, and C5,
which all gave similar and slightly better results than C1 and C4, reaching 0.31 % serum (the
composition and effect of the different combinations of supplements will be discussed later
on). In consequence of the results obtained for combinations C1 and C4, these were not used
in the second set of experiments.
Second Experiment
After identifying the problems of the first adaptation procedure, corrective measures were
implemented in a second attempt. The results of this second experiment on serum-free
adaptation are represented as a timeline in Fig. 2. Comparing the results presented in Fig. 2
with those of Fig. 1, the most notable change is the time of adaptation given at each step of
the process, which was greatly increased in this second procedure. At each level of serum,
full adaptation was assured by the observation of good cell proliferation and viability.
Concerning cell line A, Fig. 2 shows that approximately 280 days were needed to reach
serum-free conditions. In this time course, only 20 days were needed to reach cell adaptation
to 1.25 % serum, without notice of significant changes in cell behavior (growth and
morphology). Likewise, the adaptation from growth in DMEM medium to growth in the
chemically defined EX-CELL medium with 0.625 % serum was straightforward and
achieved in just 10 days. From this point on, with cells growing in EX-CELL, the process
Fig. 1 Timeline of the first attempt to adapt cell line A to serum-free medium, starting with a supplementation
of 10 % of serum. All the combinations of medium supplements (C1–C5) were used
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became more time consuming, demanding a greater effort from the cells to adapt. As can
be seen in Fig. 2, the most critical step was 0.31 % serum, the level at which the cells
started to become detached and to grow in suspension. With this change in their
behavior, it became possible to expand the cultures to new flasks without resorting to
the aggressive procedures of trypsinization and/or centrifugation. Indeed, up to this point,
cells were maintained in the same culture flasks exactly to avoid these procedures
identified as one of the reasons for the failure of the first attempt of adaptation.
However, this prevented the quantification of cell density up to the point where cells
started to grow detached (during the 0.31 % stage); therefore, the progress of this
parameter was documented by taking micrographs, as shown in Fig. 3. In this figure, it
is possible to observe that at 0.31 % serum, cells growing in medium supplemented with
C2 and C5 began to demonstrate increasing difficulties achieving healthy proliferation.
Indeed, these combinations of supplements caused a deterioration of cell concentration,
viability, and morphology over time, culminating in their death at day146. It should be
noted that the same behavior was observed for the control of cells growing in medium
without supplementation. In opposition, cells growing in medium supplemented with C3
were able to fully adapt to this level of serum and progress in the adaptation procedure.
These results indicate that the composition and concentration of the combinations used to
supplement the growth medium clearly influence the ability of the cells to adapt to
serum-free conditions, which is in accordance with previous studies [11–13]. The selec-
tion of the trace elements and respective combinations assessed in this study was based
on the composition of commercially available solutions of these compounds, on the
composition of basal culture media and serum, and on studies concerning the enhance-
ment of medium performance using trace elements [13, 15]. Specifically, the elements
copper, zinc, selenite, and iron were selected due to their often reported importance in
medium optimization, with iron, cooper, and zinc playing a role in different mechanisms
that ultimately affect cell growth, differentiation, development, and maintenance, and
selenite acting as an antioxidant [13]. The effects of the remaining traces used in this
study (Table 1) are not yet understood in in vitro cell culture, but these compounds have
been associated to several important functions in vivo, such as the metabolism of folate
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Fig. 2 Timeline of the second attempt to adapt cell line A to serum-free medium, starting with a supplemen-
tation of 10 % serum. Cell lines B and C were also subjected to the process of adaptation. Only combinations
of medium supplements C2, C3, and C5 were used
Appl Biochem Biotechnol (2013) 169:1279–1291 1285
1286 Appl Biochem Biotechnol (2013) 169:1279–1291
(nickel), support of the immune system (stannous), and maintenance of a healthy blood
sugar/insulin levels (metavanadate) [15]. Although the exact functions may not be known, the
trace compounds and their combinations can be advantageous in serum-free or even chemically
defined media. Indeed, it was interesting to note that in the present study, the combination C3,
containing the least researched trace elements, was in fact the most advantageous and the only
enabling a complete adaptation of cell line A to serum-free medium. The more extensively
researched elements of copper, zinc, selenite, and iron, present in the remaining combinations,
seemed to be detrimental for cell line A since even in combination C5, where the elements of C3
are also present, cells were unable to adapt. A possible explanation for these results is that the
influence of the trace elements in the culture is not simply additive, and according to the
combinations and concentrations of elements used, synergistic or antagonistic effects can be
obtained. Therefore, the most known elements used in combinations C1, C2, C4 and C5 could
have had antagonistic effects in the cells assessed, resulting in a negative influence on cell
growth and adaptation. One potential reason for these results is related to the presence of iron in
all the combinations with negative results. Iron is a critical component in cell culture, being
essential for a healthy cell growth. The uptake of iron by the cells is complex and usually
mediated and controlled by transferrin, which is present in the serum supplemented to the
culture medium [4, 6, 16]. However, in serum-free conditions, transferrin is absent, and iron
becomes even more critical, being common to supplement the culture with additional quantities
of this element to ensure its delivery to the cells [7]. This was the main reason for using
concentrations of iron higher than those of the remaining trace elements used in this study
(Table 1). However, the supplementation of iron without the presence of transferrin to bind this
element and control its delivery to the cells may lead to oxidative reactions that can damage the
cells (oxidative stress) or result in uncontrolled uptake of iron by the cells [9, 16]. It is possible
that this effect occurred in the present study since the differences between the combinations
containing iron and C3 only become detectable at lower levels of serum percentage, where the
levels of transferrin may have become too low to mediate iron delivery to the cells and
therefore, impair cell growth.
After adapting to the stage of 0.31 % serum, cells showed a tendency to maintain high
levels of viability that resulted in easier and faster adaptation to the remaining stages of the
process. Furthermore, at the end of the 0.075 % serum and especially during the 0 % serum
stages, cell proliferation was visibly improved (Fig. 3), making it easier to expand the culture
and create a cell bank.
In this second experiment, two additional cell lines were also assessed: cell line B (CHO-
K1 cell line ATCC CCL-61) and cell line C (CHO-K1 cell line producing CAB051 mAb,
transfected by a common technology). These cell lines had a similar behavior to cell line A
at the highest serum concentrations. However, at 0.31 % serum, with cells becoming
detached and growing in suspension, a decision was made to place the cells in rocking
conditions (35 rpm) in an attempt to promote their growth in suspension. After a short time
cultured in these conditions, the viability of cells started to decrease, and their morphology
changed to smaller and irregular cells. Therefore, agitation was removed and cells were
supplemented with an increased percentage of serum (1 %) in an attempt of recovery. With
cell line C, recovery was not possible, and cells died at day 98. As for cell line B, it was
possible to recover some cells and to proceed with the adaptation process but only down to
0.31 % serum, stage at which cells died (day156). It should be mentioned that with
Fig. 3 Microscopic images (×200 magnification) of cell line A cells growing at different stages of serum
supplementation during the process of adaptation to serum-free medium, using combinations of trace elements
C2, C3, and C5
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combinations C2 and C5, the cultures died earlier (day126), indicating that C3 is also the
best combination for the adaptation of cell line B.
Due to the negative consequences of adding rocking to the cultures of both cell line B and
cell line C, this procedure was not applied to the adaptation process of cell line A.
The different behaviors of the three CHO-K1 cell lines assessed in this study indicate that
the process of adaptation is highly cell line dependent. This constitutes a major impediment
for the definition of a general protocol for serum-free adaptation.
At each step of the process of cell adaptation to serum-free conditions, cells were
cryopreserved. When performing the thawing of these cells, it was found that they had
low viabilities (around 50 %) and took too long to recover. This was attributed to the high
sensitivity of the adapted cells, which makes them more vulnerable to centrifugation, the
presence of the toxic DMSO, as well as to the abrupt temperature and osmotic changes
involved in the cryopreservation and thawing procedures. As a consequence, it was neces-
sary to optimize both procedures, to make them more reproducible and delicate to the cells.
It was found that the use of conditioned medium in the freezing medium was favorable,
presumably due to the presence of metabolic products of cell growth that confer extra
protection to the cells. Furthermore, adding the DMSO-containing freezing medium to the
cells in a dropwise manner was also beneficial.
Regarding the process of thawing, cells should be allowed to warm rapidly at 37 °C just
until an ice crystal remains, and fresh growth medium should be added to the cells in a
dropwise manner in order to reduce osmotic shock/stress. At this point, there are two factors
of stress to the cells that need to be taken into consideration: centrifugation and the presence
of the toxic DMSO. Cells can either be centrifuged to remove the DMSO-containing
medium, which removes the toxicity of this product but introduces extra stress
(mechanical) to the cells or they can be left to grow in the DMSO-containing medium.
Both procedures were evaluated, and it was found that cells support the mechanical stress of
centrifugation better than the toxicity of DMSO, particularly at the lowest percentages of
serum, where cells are growing in suspension and it is not possible to completely renew the
medium. After centrifugation, new growth medium should also be added to the cells
dropwise. By implementing these changes in the procedures of cryopreservation and thaw-
ing, the percentage of cell recovery was raised from 50 to 90 %.
Effects of Medium Adaptation on Monoclonal Antibody Production
The different steps of the process of cell adaptation to growth in serum-free conditions may
have an important impact on their ability to produce mAbs. To evaluate this, samples were
taken from the cultures at different stages of serum supplementation, and the mAb produced
was quantified by ELISA. The results obtained are shown in Fig. 4. It is notable that a
significant (p<0.05) increase of mAb production, of about one order of magnitude, occurred
for combination C3 from 0.625 to 0.31 % of serum. It was at this point that cells were
switched from growth in DMEM culture medium to the chemically defined EX-CELL
medium. Cell density during this switch remained similar (Fig. 3), so the most probable
cause for the increase of mAb production observed is the use of EX-CELL, whose compo-
sition is specifically prepared to compensate for the absence of serum and to promote the
productivity of CHO cells. In the previous analysis of Fig. 2, it was observed that the time
required for cells to adapt to each level of serum becomes longer at 0.31 %, when cells start
growing in EX-CELL. It is possible that a metabolic shift occurs at this stage, with the main
focus of cells changing from proliferation to mAb production. Indeed, this inverse relation-
ship between cell growth and production has been often discussed as an approach to
1288 Appl Biochem Biotechnol (2013) 169:1279–1291
optimize production processes. Examples of such strategies include the use of culture
temperatures lower than the ideal for cell growth [1, 28], small changes in pH [14], and
hyperosmolarity [20]. Further reduction of serum percentage to 0.075 % and 0 % led to a
decrease in mAb production to levels that although still higher than the initial values, were
no longer significantly different. It was also at these levels of serum that cell density became
similar to that of the initial conditions (10 % serum), which may have caused a decrease of
mAb production by reducing the specific productivity of the cells, in an effect inverse to that
observed after the shift to EX-CELL.
Concerning combinations C2 and C5, there were no significant changes in mAb produc-
tion during the process of adaptation. However, these cells were only able to grow until
0.625 % serum, after which a total decay of cell proliferation occurred, culminating in their
death and an abrupt decrease of mAb production (hence, the high standard deviations
observed). Since the change of culture medium to EX-CELL at 0.625 % probably causes
a shift in the metabolic behavior of cells, it is possible that cells growing in combinations C2
and C5 were not capable of supporting such adjustment.
Comparing the three combinations of medium supplements used, no significant differ-
ences were generally detected in the levels of production at each stage of serum. However,
two exceptions were noted (p<0.05), namely for all combinations at 2.5 % serum and
between C2 and C3 at 1.25 % serum. In these cases, it is curious to note that C3 is the
combination achieving the lower levels of production.
Conclusion
The adaptation of mammalian cells to growth in serum-free conditions is still one of the most
challenging and time-consuming processes of cell culture. In this work, some basic guide-
lines were established to support the development of procedures for the adaptation of
Fig. 4 Evolution of monoclonal antibody production by CHO-K1 cells (cell line A) through the different
levels of serum percentage of the process of adaptation. Production is shown for cells growing in the three
combinations of medium supplements tested (C2, C3, and C5). (1) The high standard deviations are a
consequence of the abrupt mAb production decrease associated with cell death at this level of serum. Single
asterisk (*) represents statistical differences (p<0.05) between serum concentrations
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different cells lines to growth in serum-free conditions. These guidelines identify the most
potentially damaging procedures of the process, such as centrifugation, trypsinization, and
cryopreservation, and highlight the importance of the selection of medium supplements (e.g.
trace elements) to use during cell adaptation. Indeed, among the five supplement combina-
tions assessed in this study, only the combination of ammonium metavanadate, nickel
chloride and stannous chloride (C3) resulted in the successful adaptation of CHO-K1 cells
to serum-free medium. However, it must be highlighted that the amount of time given at
each step of the process, as well as the cell type, are determinant factors for the success of the
process of adaptation, and therefore the support protocol here defined should be adapted to
the particular requirements of each cell line.
The process of adaptation also affected the levels of mAb production, in two ways:
the shift of medium from DMEM to the chemically defined EX-CELL benefited mAb
production and the complete removal of serum from the culture reduced these positive
effects but still resulted in levels of production slightly superior to those of the initial
serum-supplemented conditions.
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